Target intelligence / Profile preview

DNA topoisomerase 2-DNA cleavage complex (TOP2cc) (TOP2cc)

Target
TOP2cc
Molecular classification
Enzyme-DNA complex, Type II topoisomerase
01

Overview

The Topoisomerase II–DNA cleavage complex (TOP2cc) is a transient, covalent intermediate formed during the catalytic cycle of type II topoisomerases, which are essential enzymes that manage DNA topology by resolving knots and tangles [1, 6]. During its function, the enzyme creates a double-stranded break in a "gate" DNA segment, covalently binds to the 5' ends, and passes another DNA duplex through the gap before religating the break [3, 5, 7]. This complex is the specific target of "topoisomerase II poisons," such as etoposide and anthracyclines, which stabilize the intermediate and prevent the religation of the DNA strands [4, 8, 13]. By trapping the enzyme in this state, these drugs convert an essential cellular machine into a potent toxin that generates persistent double-strand breaks, ultimately triggering apoptosis in rapidly proliferating cancer cells [1, 10, 15]. However, the persistence of TOP2cc can also lead to deleterious genomic rearrangements, such as MLL gene translocations, which are associated with the development of secondary leukemias [3, 9, 14]. Furthermore, the interaction of drugs with the TOP2B isoform in non-proliferating cells like cardiomyocytes is a primary driver of treatment-related cardiotoxicity [8, 13].

Other names
Topoisomerase II-DNA cleavage complexTopoisomerase II-DNA covalent complexTop2 cleavage complexTOP2-DNA complexCleavable complex
02

Mechanism of action

Stabilization of the topoisomerase II-DNA cleavage complex and inhibition of DNA religation, leading to permanent double-strand breaks and apoptosis.

03

Biological functions

DNA replicationTranscriptionChromosome segregationDNA repairDNA topology regulation
04

Disease associations

CancerLeukemia
05

Safety considerations

Secondary malignancies (e.g., acute myeloid leukemia)CardiotoxicityMyelosuppressionGenotoxicity
06

Interacting drugs

Etoposide

7 more in the full profile.

07

Biomarkers

TOP2A expressionTOP2B expressiongamma-H2AXMLL gene translocation

Beyond the preview

Go deeper on DNA topoisomerase 2-DNA cleavage complex (TOP2cc) (TOP2cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 2-DNA cleavage complex (TOP2cc) (TOP2cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call